PPLPHARMA Piramal Pharma Ltd Earnings Reports Announcement 2025 - Q4 FY2025 Results Piramal Pharma Ltd reported its financial results for Q4 and FY2025, achieving 12% year-on-year revenue growth and crossing $1 billion in revenues. The consolidated PAT after exceptional items was Rs 154 crore, reflecting a significant 52% increase compared to the previous period..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Piramal Pharma Ltd